Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.


Journal

Signal transduction and targeted therapy
ISSN: 2059-3635
Titre abrégé: Signal Transduct Target Ther
Pays: England
ID NLM: 101676423

Informations de publication

Date de publication:
17 05 2021
Historique:
received: 08 02 2021
accepted: 18 03 2021
revised: 08 03 2021
entrez: 18 5 2021
pubmed: 19 5 2021
medline: 1 6 2021
Statut: epublish

Résumé

Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SARS-CoV-2 replication. Meplazumab is a humanized anti-CD147 IgG

Identifiants

pubmed: 34001849
doi: 10.1038/s41392-021-00603-6
pii: 10.1038/s41392-021-00603-6
pmc: PMC8127508
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
meplazumab 0EL07E29VQ

Types de publication

Clinical Trial, Phase I Clinical Trial, Phase II Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

194

Références

Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Hong Kong Med J. 2008 Aug;14 Suppl 4:21-6
pubmed: 18708670
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Signal Transduct Target Ther. 2020 Dec 4;5(1):283
pubmed: 33277466
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Clin Rheumatol. 2018 Jan;37(1):59-66
pubmed: 28948414
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Emerg Med Clin North Am. 2007 Nov;25(4):1117-35, vii
pubmed: 17950138
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
PLoS Med. 2020 Jul 28;17(7):e1003189
pubmed: 32722715
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Acta Pharm Sin B. 2020 Sep;10(9):1680-1693
pubmed: 33088688
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Biosaf Health. 2021 Apr;3(2):87-91
pubmed: 33585808
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Ann Intern Med. 2020 Dec 15;173(12):1015-1017
pubmed: 32931326
Sci China Life Sci. 2020 Mar;63(3):364-374
pubmed: 32048163
BMJ. 2020 Nov 11;371:m4362
pubmed: 33177042
Blood. 2018 Mar 8;131(10):1111-1121
pubmed: 29352039

Auteurs

Huijie Bian (H)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China. hjbian@fmmu.edu.cn.

Zhao-Hui Zheng (ZH)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Ding Wei (D)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Aidong Wen (A)

Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Zheng Zhang (Z)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Jian-Qi Lian (JQ)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Wen-Zhen Kang (WZ)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Chun-Qiu Hao (CQ)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Jing Wang (J)

Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Rong-Hua Xie (RH)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Ke Dong (K)

Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Jie-Lai Xia (JL)

College of Military Preventive Medicine, Fourth Military Medical University, Xi'an, China.

Jin-Lin Miao (JL)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Wen Kang (W)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Guoquan Li (G)

Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Di Zhang (D)

Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Mingru Zhang (M)

Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Xiu-Xuan Sun (XX)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Likun Ding (L)

Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Kui Zhang (K)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Junfeng Jia (J)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Jin Ding (J)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Zhiqin Li (Z)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Yanyan Jia (Y)

Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Lin-Na Liu (LN)

Department of Pharmaceutics, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Zhe Zhang (Z)

Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Zhao-Wei Gao (ZW)

Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Hong Du (H)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Na Yao (N)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Qing Wang (Q)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Ke Wang (K)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Jie-Jie Geng (JJ)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Bin Wang (B)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Ting Guo (T)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Ruo Chen (R)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Yu-Meng Zhu (YM)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Li-Juan Wang (LJ)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Qian He (Q)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Rui-Rui Yao (RR)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Ying Shi (Y)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Xiang-Min Yang (XM)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Jian-Sheng Zhou (JS)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Yi-Nan Ma (YN)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Ya-Tao Wang (YT)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Xue Liang (X)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Fei Huo (F)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Zhe Wang (Z)

Department of Pathology, Fourth Military Medical University, Xi'an, China.

Yang Zhang (Y)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Xu Yang (X)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China.

Ye Zhang (Y)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Lu-Hua Gao (LH)

Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Ling Wang (L)

College of Military Preventive Medicine, Fourth Military Medical University, Xi'an, China.

Xiao-Chun Chen (XC)

Jiangsu Pacific Meinuoke Biopharmaceutical Co. Ltd, Changzhou, China.

Hao Tang (H)

Jiangsu Pacific Meinuoke Biopharmaceutical Co. Ltd, Changzhou, China.

Shuang-Shuang Liu (SS)

Jiangsu Pacific Meinuoke Biopharmaceutical Co. Ltd, Changzhou, China.

Qing-Yi Wang (QY)

Department of Foreign Languages, Fourth Military Medical University, Xi'an, China.

Zhi-Nan Chen (ZN)

National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, China. znchen@fmmu.edu.cn.

Ping Zhu (P)

Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. zhuping@fmmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH